Walleye Trading LLC Novo Nordisk A S Put Options Transaction History

Walleye Trading LLC

$46.7 Billion
Q3 2024

Put Options

29 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $21.3 Million - $26 Million	178,900 Added 188.51%	273,800 $32.6 Million
Q2 2024 Aug 14, 2024	SELL	$122.71 - $146.91 $3.83 Million - $4.58 Million	-31,200 Reduced 24.74%	94,900 $13.5 Million
Q1 2024 May 15, 2024	SELL	$102.11 - $135.92 $6.9 Million - $9.19 Million	-67,600 Reduced 34.9%	126,100 $16.2 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $8.55 Million - $10.3 Million	-97,400 Reduced 33.46%	193,700 $20 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $6.52 Million - $14.3 Million	71,700 Added 32.68%	291,100 $26.5 Million
Q2 2023 Aug 14, 2023	BUY	$155.98 - $172.65 $21.1 Million - $23.4 Million	135,500 Added 161.5%	219,400 $35.5 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $5.28 Million - $6.35 Million	39,900 Added 90.68%	83,900 $13.4 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $6.48 Million - $8.55 Million	-63,200 Reduced 58.96%	44,000 $5.95 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $2.73 Million - $3.36 Million	28,700 Added 36.56%	107,200 $10.7 Million
Q2 2022 Aug 08, 2022	BUY	$103.24 - $121.81 $7.09 Million - $8.37 Million	68,700 Added 701.02%	78,500 $8.75 Million
Q1 2022 May 16, 2022	SELL	$93.1 - $112.54 $1.06 Million - $1.28 Million	-11,400 Reduced 53.77%	9,800 $1.09 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $172,584 - $210,744	-1,800 Reduced 7.83%	21,200 $2.37 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $1.72 Million - $2.18 Million	20,400 Added 784.62%	23,000 $2.21 Million
Q1 2021 May 17, 2021	SELL	$67.06 - $75.82 $214,592 - $242,623	-3,200 Reduced 55.17%	2,600 $175,000
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $319,450 - $369,000	-5,000 Reduced 46.3%	5,800 $405,000
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $1.65 Million - $1.82 Million	-25,900 Reduced 70.57%	10,800 $750,000
Q2 2020 Aug 14, 2020	BUY	$58.54 - $67.94 $1.73 Million - $2.01 Million	29,600 Added 416.9%	36,700 $2.4 Million
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $1.88 Million - $2.47 Million	-38,100 Reduced 84.29%	7,100 $427,000
Q4 2019 Feb 14, 2020	BUY	$49.86 - $58.26 $867,564 - $1.01 Million	17,400 Added 62.59%	45,200 $2.62 Million
Q3 2019 Nov 14, 2019	SELL	$47.54 - $53.43 $23,770 - $26,715	-500 Reduced 1.77%	27,800 $1.44 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $1.68 Million - $1.89 Million	-36,000 Reduced 55.99%	28,300 $1.44 Million
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $1.88 Million - $2.13 Million	-40,500 Reduced 38.65%	64,300 $3.36 Million
Q4 2018 Feb 14, 2019	SELL	$41.54 - $47.25 $1.41 Million - $1.61 Million	-34,000 Reduced 24.5%	104,800 $4.83 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $2.74 Million - $3 Million	58,500 Added 72.85%	138,800 $6.54 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $2.99 Million - $3.41 Million	67,600 Added 532.28%	80,300 $3.7 Million
Q1 2018 May 15, 2018	SELL	$48.49 - $58.14 $465,504 - $558,144	-9,600 Reduced 43.05%	12,700 $625,000
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $23,765 - $26,865	-500 Reduced 2.19%	22,300 $1.2 Million
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $358,005 - $428,214	8,700 Added 61.7%	22,800 $1.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	14,100	14,100 $605,000

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$2.18 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.55 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.55 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.44 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.32 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.

Account